CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions
Related Posts
Zeng L, Hsu YC, Wang L, Lu M, Keushkerian M, Nguyen KL, Johnson KJ, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner[...]
Whitley MJ, Wang JX, Chapman J, de Vries APJ, Chandran S, Glennon CM, Madariaga HM, Carroll RP, Booth J, Concepcion B, Couzi L, De Serres[...]
Scranton K, John S, Angelini M, Zhang R, Schwingshackl A, Goldhaber JI, Olcese R, Ottolia M. The mechanism of action of digoxin requires the sodium-dependent[...]